PCM
CC icon

Portolan Capital Management’s Chemours CC Stock Holding History

Portolan Capital Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-307,625
Closed -$6.43M – 170
2020
Q3 		$6.43M Sell
307,625
-81,556
-21% -$1.57M 0.73% 56
2020
Q2 		$5.97M Buy
+389,181
New +$4.92M 0.68% 59

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Portolan Capital Management's CC Position: Q4 2020 in Review

Portolan Capital Management sold out of Chemours (CC) in Q4 2020, closing a stake of 307,625 shares — an estimated $6.43M sold.

Portolan Capital Management first reported a position in CC in Q2 2020 and held it in 2 quarters. The position peaked at $6.43M in Q3 2020. 429 funds tracked by Wall St. Rank hold CC as of Q4 2020.

  • Portolan Capital Management reported no remaining Chemours position as of Q4 2020 after selling out during the quarter.
  • Portolan Capital Management sold 307,625 Chemours shares in Q4 2020, an estimated $6.43M.
  • Portolan Capital Management first reported a position in Chemours in Q2 2020 and held it in 2 quarters.
  • Portolan Capital Management's Chemours position peaked at $6.43M in Q3 2020.
  • 429 funds tracked by Wall St. Rank held Chemours as of Q4 2020.

Based on Portolan Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.